Trials / Conditions / Malignant Neoplasm of Lung
Malignant Neoplasm of Lung
5 registered clinical trials studyying Malignant Neoplasm of Lung.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21) NCT05853575 | Mirati Therapeutics Inc. | Phase 2 |
| Active Not Recruiting | Study of Avutometinib (VS-6766) + Adagrasib in KRAS G12C NSCLC Patients NCT05375994 | Verastem, Inc. | Phase 1 / Phase 2 |
| Terminated | Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14) NCT04975256 | Mirati Therapeutics Inc. | Phase 1 |
| Unknown | Single Pulmonary Nodule Investigation NCT02013063 | University Hospital Southampton NHS Foundation Trust | — |
| Completed | Endobronchial Valves in Persistent Air Leak NCT01451359 | Universitaire Ziekenhuizen KU Leuven | N/A |